Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2000
03/16/2000WO2000014268A1 Modulation of microbial metabolism and/or growth rate by plant growth hormones
03/16/2000WO2000014265A1 Enzymatic oxidative deamination process
03/16/2000WO2000014259A1 Candida boidinii strains having lowered protease activity and utilization thereof as host for producing foreign protein
03/16/2000WO2000014258A1 Method for the production of heterologous polypeptides in transformed yeast cells
03/16/2000WO2000014253A1 Nucleic acids and proteins from pineapple stem
03/16/2000WO2000014250A1 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/16/2000WO2000014249A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000WO2000014246A1 Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof
03/16/2000WO2000014243A1 Phenolic acid esterases, coding sequences and methods
03/16/2000WO2000014242A1 Novel protein, gene encoding the same and utilization thereof
03/16/2000WO2000014241A1 Novel gene
03/16/2000WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000WO2000014229A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same
03/16/2000WO2000014227A1 Novel protein and dna thereof
03/16/2000WO2000014221A1 Glycine transporter
03/16/2000WO2000014212A1 Novel protein kinase molecules and uses therefor
03/16/2000WO2000014209A1 Endothelial cell proliferation inhibitors derived from human prothrombin
03/16/2000WO2000014206A2 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000WO2000014201A1 Polypeptides containing modified, non-natural amino acids and methods of production
03/16/2000WO2000014200A2 Essential bacterial genes and their use
03/16/2000WO2000014052A1 Microbial process for the preparation of acetic acid as well as solvent for its extraction from the fermentation broth
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000013654A2 A carotenoid composition containing phytoene and phytofluene
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO2000003029A3 Chimaeric adenoviruses
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO1999067391A9 Origin of replication and methods of use
03/16/2000WO1999065937A9 Truncated apaf-1 and methods of use thereof
03/16/2000WO1999064598A3 Novel insulin analogs with enhanced zinc binding
03/16/2000WO1999064592A9 Green fluorescent proteins for measuring the ph of a biological sample
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
03/16/2000WO1999051723A3 Bacterial transglutaminases
03/16/2000CA2342792A1 Enzymatic oxidative deamination process
03/16/2000CA2342311A1 Novel protein kinase molecules and uses therefor
03/16/2000CA2342124A1 Nucleic acid molecules encoding an amylosucrase
03/16/2000CA2342115A1 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
03/16/2000CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
03/16/2000CA2341327A1 Novel protein and dna thereof
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2341154A1 Novel receptor protein and method for the diagnosis of an inflammatory disease by using the same
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000CA2340581A1 Phenolic acid esterases, coding sequences and methods
03/16/2000CA2340331A1 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
03/16/2000CA2309212A1 Essential bacterial genes and their use
03/15/2000EP0985730A1 Method for cloning and producing the snaBI restriction endonuclease and purification thereof
03/15/2000EP0985729A2 Streptokinase mutants
03/15/2000EP0985045A2 Modulators of morphogen expression and methods of identifying the same
03/15/2000EP0985043A2 Lactic acid bacterial starter cultures and compositions thereof
03/15/2000EP0985039A2 Artificial antibody polypeptides
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985036A1 Zinc ring protein
03/15/2000EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
03/15/2000EP0985034A1 Methods of controlling beta dimer formation in hemoglobin
03/15/2000EP0985030A2 New human ribonuclease
03/15/2000EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor
03/15/2000EP0984984A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/15/2000EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
03/15/2000EP0764215B1 Conditioned culture medium for rapid growth and detection of microbes
03/15/2000EP0734441B1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0649468B1 Soluble cr1 derivatives
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0563311B1 Improved vaccines
03/15/2000EP0551325B1 Method of testing for salmonella
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6
03/15/2000CN1247566A Novel peptide, novel DNA, and novel antibody
03/15/2000CN1247565A Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for biosynthesis of astaxanthin
03/15/2000CN1247230A Xylitol dehydrogenase of acetobacter and its gene
03/15/2000CN1050268C Tremella ferment beverage and process for preparing same
03/14/2000US6037526 Method of inserting viral DNA into plant material
03/14/2000US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037164 Human parvulin-like protein
03/14/2000US6037158 Lactobacillus alcohol dehydrogenase which reacts with acetophenone to form r-phenylethanol
03/14/2000US6037154 Method of producing L-serine by fermentation
03/14/2000US6037153 Producing l-ribulose, d-xylulose, d-tagatose, d-fructose, l-psicose or l-sorbose from l-ribose, d-lyxose, d-talose, d-mannose, l-allose or l-gulose using enzyme
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037147 Nucleotide sequence coding electron transfer protein
03/14/2000US6037145 Synthesizing staphlococcus protease; transforming cells with an expression vector comprising a gene coding for fusion protein, culturing transformed cells to express an insoluble fusion protein, recovering polypeptide
03/14/2000US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis
03/14/2000US6037119 Screening for modulators of enzyme activity; propagating cells transformed or transfected with nucleotide sequences coding guanosine monophosphate, preparing extracts, screening for modulators
03/14/2000US6037116 Isotonic mixture free of iodide, dihydrogen phosphate, bicarbonate, nitrate and bisulfate; low toxicity resulting in fewer negative side effects when used for transplant organs
03/14/2000US6036954 Polypeptides with sequence
03/14/2000US6036953 Dna encoding with escherichia coli and fusion polypeptides
03/14/2000US6036940 Compositions and methods relating to the production, isolation, and modification of gas vesicles
03/14/2000CA2281935A1 Streptomyces avermitilis regulatory genes for increased avermectin production
03/14/2000CA2281852A1 An antifungal lactone compound
03/14/2000CA2163081C Thermoresistant alpha-1-antitrypsin mutein
03/14/2000CA2010778C Bioactive agents, compositions and materials comprising said bioactive agents
03/14/2000CA1340924C Structural phosphoprotein (pp 150) of human cytomegalovirus, and the preparation thereof
03/09/2000WO2000012748A1 Organisms for the extracellular production of riboflavin
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012736A2 A new method of identifying non-host plant disease resistance genes
03/09/2000WO2000012735A2 Transgene assay using stable agrobacterium rhizogenes transformation